ホームページ Cytoskeletal Signaling Antineoplastic and Immunosuppressive Antibiotics inhibitor - Autophagy modulator - Microtubule Associated inhibitor - Apoptosis related activator Vincristine sulfate For research use only.

Vincristine sulfate

別名：Leurocristine sulfate, NSC-67574 sulfate, 22-Oxovincaleukoblastine sulfate

Vincristine sulfate is an inhibitor of polymerization of microtubules by binding to tubulin with IC50 of 32 μM in a cell-free assay. Vincristine sulfate induces apoptosis.

Vincristine sulfate化学構造

CAS No. 2068-78-2

サイズ 価格(税別) 在庫状況
10mM (1mL in DMSO) JPY 29500 国内在庫あり
JPY 22000 国内在庫あり
JPY 55500 国内在庫あり
JPY 130500 国内在庫あり
JPY 445500 国内在庫なし(納期7~10日)

代表番号: 045-509-1970|電子メール：[email protected]
よく尋ねられる質問

文献中Selleckの製品使用例（115）

製品安全説明書

現在のバッチを見る： 純度： 99.94%
99.94

Vincristine sulfate関連製品

Antineoplastic and Immunosuppressive Antibiotics阻害剤の選択性比較

Cell Data

Cell Lines Assay Type Concentration Incubation Time 活性情報 PMID
H1299/ICAM-3 Cell Viability Assay 0-20 nM 96 h inhibits cell viability dose dependently 24177012
NCI-H1299/pcDNA3 Cell Viability Assay 0-20 nM 96 h inhibits cell viability dose dependently 24177012
Ramos Apoptosis Assay 2 μM 48 h induces 34.6%±1.92% apoptosis 24256491
CCD18Co Growth Inhibition Assay 0-1000 nM 48 h inhibits cell growth dose dependently 24403453
DLD-1 Growth Inhibition Assay 0-1000 nM 48 h inhibits cell growth dose dependently 24403453
CCD18Co Function Assay 100 nM 48 h promotes RUNX3 demethylation  24403453
DLD-1 Function Assay 100 nM 48 h promotes RUNX3 demethylation  24403453
U-251MG Growth Inhibition Assay 0.1 μM 24/72 h inhibits cell growth time dependently 24530235
A-172  Growth Inhibition Assay 0.1 μM 24/72 h inhibits cell growth time dependently 24530235
SUDHL6  Function Assay 1 μM 72 h induces significant apoptotic morphology changes cotrested with BCL11A siRNA 24961604
SUDHL6  Growth Inhibition Assay 1 μM 48/72 h inhibits cell viability significantly 24961604
P12 Growth Inhibition Assay 1-3 nM 48 h decreases viable cell numbers dose dependently 25156146
CEM Growth Inhibition Assay 1-3 nM 48 h decreases viable cell numbers dose dependently 25156146
Jurkat Growth Inhibition Assay 1-3 nM 48 h decreases viable cell numbers dose dependently 25156146
SK-MEL-28  Function Assay 30 nM 6 h induces G2–M cell-cycle arrest 25313010
Raji Function Assay 0.5 μM 72 h abolishes autophagy  25446377
HepG2-HBV1.1 Growth Inhibition Assay 0.1 μM 12-72 h induces cell cycle arrest at S-phase 25663769
HepG2-HBV1.1 Growth Inhibition Assay 0.1 μM 12-72 h induces cell cycle arrest at S-phase 25663769
HepG2-HBV1.1 Growth Inhibition Assay 0.1 μM 1-5 d inhibits the proliferation time dependently 25663769
HepG2-HBV1.1 Growth Inhibition Assay 0.1 μM 1-5 d inhibits the proliferation time dependently 25663769
HepG2-HBV1.1 Function Assay 0.1 μM 48 h promotes cell excretion of hepatitis B virus nucleocapsids instead of hepatitis B virus Dane particles 25663769
HepG2-HBV1.1 Function Assay 0.1 μM 24 h promotes hepatitis B virus protein expression 25663769
HepG2.2.15 Function Assay 0.1 μM 24 h promotes hepatitis B virus protein expression 25663769
HepG2-HBV1.1 Apoptosis Assay 0-0.5 μM 24 h induces apoptosis dose dependently 25663769
HepG2.2.15 Cell Viability Assay 0-0.5 μM 24 h decreases cell viability dose dependently 25663769
NCI-H1299/pcDNA3 Function Assay 1/5/10/20 nM 96 h induces cleavage of caspases-3, 8, 9, and PARP 24177012
H1299/ICAM-3 Function Assay 1/5/10/20 nM 96 h induces cleavage of caspases-3, 8, 9, and PARP 24177012
K562 Apoptosis Assay 0.3 μM 24 h induces apoptosis significantly 24135937
K562/ADR Apoptosis Assay 3 μM 24 h induces apoptosis 24135937
K562 Cell Viability Assay 3.75–60 nM 72 h  inhibits cell viability dose dependently 23877223
lucena Cell Viability Assay 3.75–60 nM 72 h  no effect 23877223
FEPS Cell Viability Assay 3.75–60 nM 72 h  no effect 23877223
Jurkat Apoptosis Assay 5 μg/ml  24 h induces apoptosis significantly 23810409
Jurkat Growth Inhibition Assay 5 μg/ml  24 h arrest Jurkat cells in G2/M phase 23810409
SGC-7901 Growth Inhibition Assay 0-10 μg/ml 24/48/72 h inhibits cell growth in dose and time dependent manner 23743572
SGC-7901/VCR Growth Inhibition Assay 0-10 μg/ml 24/48/72 h inhibits cell growth in dose and time dependent manner 23743572
JFCR39  Growth Inhibition Assay 1 µM 24 h markedly increases the number of G2/M phase cells 23598276
A549 Function Assay 100 nM 16 h leads to a loss of microtubules 23598276
SH-SY5Y  Growth Inhibition Assay 0.001-10 μM 24 h IC50=0.113±0.012 μM 23129065
SH-SY5Y  Growth Inhibition Assay 0.001-10 μM 48 h IC50=0.078±0.009 μM 23129065
SH-SY5Y  Growth Inhibition Assay 0.001-10 μM 72 h IC50=0.051±0.008 μM 23129065
SH-SY5Y Apoptosis Assay 0.1 μM 0-24 h induces apoptosis of SH-SY5Y cells following cell cycle arrest at the G2/M phase 23129065
SH-SY5Y Apoptosis Assay 0.1 μM 0-24 h induces mitotic arrest  23129065
A549/EGFP  Growth Inhibition Assay 0.01-1000 μM IC50=86.7 ± 29.1 μM 23634282
A549/Slug Growth Inhibition Assay 0.01-1000 μM IC50=9.7 ± 3.1 μM 23634282
HepG2 Growth Inhibition Assay 24 h IC50=52.5 μM 24341688
TCC Growth Inhibition Assay 48 h IC50=50 nM 24716944
TCC Growth Inhibition Assay 24 h IC50=70 nM 24716944
LNCAP Cytotoxicity assay 72 hrs Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay, IC50 = 0.0029 μM. 20732809
LNCAP Cytotoxicity assay 72 hrs Cytotoxicity against human LNCAP cells after 72 hrs by alamar blue assay, IC50 = 0.0061 μM. 23215348
PC3 Cytotoxicity assay 72 hrs Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay, IC50 = 0.011 μM. 20732809
PC3 Cytotoxicity assay 72 hrs Cytotoxicity against human PC3 cells after 72 hrs by alamar blue assay, IC50 = 0.015 μM. 23215348
PC3 Cytotoxicity assay 72 hrs Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay, IC50 = 0.0153 μM. 23489291
NFF Cytotoxicity assay 72 hrs Cytotoxicity against human NFF cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay, IC50 = 0.0169 μM. 23489291
NFF Cytotoxicity assay 72 hrs Cytotoxicity against human NFF cells after 72 hrs by alamar blue assay, IC50 = 0.017 μM. 23215348
A549 Cytotoxicity assay 72 hrs Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay, IC50 = 0.02 μM. 23215348
KB Cytotoxicity assay 72 hrs Cytotoxicity against human KB cells after 72 hrs by SRB assay, IC50 = 0.02 μM. 26522953
PC3 Antiproliferative assay 48 hrs Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay, IC50 = 0.0276 μM. 28038323
HEK Cytotoxicity assay 72 hrs Cytotoxicity against human HEK cells after 72 hrs by alamar blue assay, IC50 = 0.031 μM. 23215348
HeLa Cytotoxicity assay 72 hrs Cytotoxicity against human HeLa cells assessed as inhibition of cell viability after 72 hrs by alamar blue assay, IC50 = 0.0358 μM. 23489291
HeLa Cytotoxicity assay 72 hrs Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay, IC50 = 0.036 μM. 23215348
BT549 Antiproliferative assay 48 hrs Antiproliferative activity against human BT549 cells after 48 hrs by MTT assay, IC50 = 0.05472 μM. 28038323
DU145 Antiproliferative assay 48 hrs Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay, IC50 = 0.0723 μM. 28038323
Leukemia cells Antitumor assay 48 hrs Antitumor activity against human Leukemia cells after 48 hrs by SRB assay, GI50 = 0.1 μM. 19006285
Leukemia cells Antitumor assay 48 hrs Antitumor activity against human Leukemia cells after 48 hrs by SRB assay, GI = 0.1 μM. 19006285
Colon cancer cells Antitumor assay 48 hrs Antitumor activity against human Colon cancer cells after 48 hrs by SRB assay, GI50 = 0.1 μM. 19006285
Colon cancer cells Antitumor assay 48 hrs Antitumor activity against human Colon cancer cells after 48 hrs by SRB assay, GI = 0.1 μM. 19006285
Leukemia cells Growth inhibition assay 48 hrs Growth inhibition of human leukemia cells after 48 hrs, GI50 = 0.1 μM. 20684599
Colon cancer cells Growth inhibition assay 48 hrs Growth inhibition of human colon cancer cells after 48 hrs, GI50 = 0.1 μM. 20684599
Leukemia cells Cytotoxicity assay 48 hrs Cytotoxicity against human leukemia cells after 48 hrs, GI50 = 0.1 μM. 24747749
Colon cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human colon cancer cells after 48 hrs, GI50 = 0.1 μM. 24747749
Leukemia cells Cytotoxicity assay 48 hrs Cytotoxicity against human leukemia cells after 48 hrs, GI50 = 0.1 μM. 22283430
Colon cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human COLON cells after 48 hrs, GI50 = 0.1 μM. 22283430
MDA-MB-231 Antiproliferative assay 48 hrs Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay, IC50 = 0.1166 μM. 28038323
CNS Antitumor assay 48 hrs Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay, GI50 = 0.12589 μM. 19006285
prostate cancer cells Antitumor assay 48 hrs Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay, GI50 = 0.12589 μM. 19006285
CNS Antitumor assay 48 hrs Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay, GI = 0.13 μM. 19006285
prostate cancer cells Antitumor assay 48 hrs Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay, GI = 0.13 μM. 19006285
prostate cancer cells Growth inhibition assay 48 hrs Growth inhibition of human prostate cancer cells after 48 hrs, GI50 = 0.13 μM. 20684599
CNS Growth inhibition assay 48 hrs Growth inhibition of human CNS cancer cells after 48 hrs, GI50 = 0.13 μM. 20684599
CNS Cytotoxicity assay 48 hrs Cytotoxicity against human CNS cancer cells after 48 hrs, GI50 = 0.13 μM. 24747749
prostate cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human prostate cancer cells after 48 hrs, GI50 = 0.13 μM. 24747749
prostate cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human prostate cancer cells after 48 hrs, GI50 = 0.13 μM. 22283430
CNS Cytotoxicity assay 48 hrs Cytotoxicity against human CNS cancer cells after 48 hrs, GI50 = 0.13 μM. 22283430
Melanoma cells Antitumor assay 48 hrs Antitumor activity against human Melanoma cells after 48 hrs by SRB assay, GI50 = 0.15849 μM. 19006285
Melanoma cells Antitumor assay 48 hrs Antitumor activity against human Melanoma cells after 48 hrs by SRB assay, GI = 0.16 μM. 19006285
Melanoma cells Cytotoxicity assay 48 hrs Cytotoxicity against human melanoma cells after 48 hrs, GI50 = 0.16 μM. 24747749
Melanoma cells Cytotoxicity assay 48 hrs Cytotoxicity against human melanoma cells after 48 hrs, GI50 = 0.16 μM. 22283430
A549 Antiproliferative assay 48 hrs Antiproliferative activity against human A549 cells after 48 hrs by MTT assay, IC50 = 0.1715 μM. 28038323
NSCLC Antitumor assay 48 hrs Antitumor activity against human NSCLC cells after 48 hrs by SRB assay, GI = 0.25 μM. 19006285
NSCLC Growth inhibition assay 48 hrs Growth inhibition of human NSCLC cells after 48 hrs, GI50 = 0.25 μM. 20684599
NSCLC Cytotoxicity assay 48 hrs Cytotoxicity against human NSCLC cells after 48 hrs, GI50 = 0.25 μM. 22283430
NSCLC Cytotoxicity assay 48 hrs Cytotoxicity against human NSCLC cells after 48 hrs, GI50 = 0.25 μM. 24747749
NSCLC Antitumor assay 48 hrs Antitumor activity against human NSCLC cells after 48 hrs by SRB assay, GI50 = 0.25119 μM. 19006285
ovarian cancer cells Antitumor assay 48 hrs Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay, GI50 = 0.31623 μM. 19006285
renal cancer cells Antitumor assay 48 hrs Antitumor activity against human renal cancer cells after 48 hrs by SRB assay, GI50 = 0.31623 μM. 19006285
breast cancer cells Antitumor assay 48 hrs Antitumor activity against human Breast cancer cells after 48 hrs by SRB assay, GI50 = 0.31623 μM. 19006285
ovarian cancer cells Antitumor assay 48 hrs Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay, GI = 0.32 μM. 19006285
renal cancer cells Antitumor assay 48 hrs Antitumor activity against human renal cancer cells after 48 hrs by SRB assay, GI = 0.32 μM. 19006285
breast cancer cells Antitumor assay 48 hrs Antitumor activity against human Breast cancer cells after 48 hrs by SRB assay, GI = 0.32 μM. 19006285
renal cancer cells Growth inhibition assay 48 hrs Growth inhibition of human renal cancer cells after 48 hrs, GI50 = 0.32 μM. 20684599
breast cancer cells Growth inhibition assay 48 hrs Growth inhibition of human breast cancer cells after 48 hrs, GI50 = 0.32 μM. 20684599
ovarian cancer cells Growth inhibition assay 48 hrs Growth inhibition of human Ovarian cancer cells after 48 hrs, GI50 = 0.32 μM. 20684599
breast cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human breast cancer cells after 48 hrs, GI50 = 0.32 μM. 24747749
renal cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human renal cancer cells after 48 hrs, GI50 = 0.32 μM. 24747749
ovarian cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human ovarian cancer cells after 48 hrs, GI50 = 0.32 μM. 24747749
renal cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human renal cancer cells after 48 hrs, GI50 = 0.32 μM. 22283430
ovarian cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human ovarian cancer cells after 48 hrs, GI50 = 0.32 μM. 22283430
breast cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human breast cancer cells after 48 hrs, GI50 = 0.32 μM. 22283430
Lu1 Cytotoxicity assay 72 hrs Cytotoxicity against human Lu1 cells after 72 hrs by SRB assay, IC50 = 0.48 μM. 26522953
MCF7 Cytotoxicity assay 72 hrs Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay, IC50 = 0.51 μM. 26522953
HepG2 Cytotoxicity assay 72 hrs Cytotoxicity against human HepG2 cells after 72 hrs by SRB assay, IC50 = 0.69 μM. 26522953
COLON Growth inhibition assay 48 hrs Growth inhibition of human colon cancer cells after 48 hrs, TGI = 3.98 μM. 20684599
COLON Cytotoxicity assay 48 hrs Cytotoxicity against human colon cancer cells after 48 hrs, TGI = 3.98 μM. 24747749
COLON Cytotoxicity assay 48 hrs Cytotoxicity against human COLON cells after 48 hrs, TGI = 3.98 μM. 22283430
COLON Antitumor assay 48 hrs Antitumor activity against human Colon cancer cells after 48 hrs by SRB assay, TGI = 3.98107 μM. 19006285
CNS Antitumor assay 48 hrs Antitumor activity against human CNS cancer cells after 48 hrs by SRB assay, TGI = 6.30957 μM. 19006285
prostate cancer cells Antitumor assay 48 hrs Antitumor activity against human prostate cancer cells after 48 hrs by SRB assay, TGI = 6.30957 μM. 19006285
prostate cancer cells Growth inhibition assay 48 hrs Growth inhibition of human prostate cancer cells after 48 hrs, TGI = 6.31 μM. 20684599
CNS Growth inhibition assay 48 hrs Growth inhibition of human CNS cancer cells after 48 hrs, TGI = 6.31 μM. 20684599
CNS Cytotoxicity assay 48 hrs Cytotoxicity against human CNS cancer cells after 48 hrs, TGI = 6.31 μM. 24747749
prostate cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human prostate cancer cells after 48 hrs, TGI = 6.31 μM. 24747749
prostate cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human prostate cancer cells after 48 hrs, TGI = 6.31 μM. 22283430
CNS Cytotoxicity assay 48 hrs Cytotoxicity against human CNS cancer cells after 48 hrs, TGI = 6.31 μM. 22283430
Melanoma cells Growth inhibition assay 48 hrs Growth inhibition of human melanoma cells after 48 hrs, TGI = 7.94 μM. 20684599
breast cancer cells Growth inhibition assay 48 hrs Growth inhibition of human breast cancer cells after 48 hrs, TGI = 7.94 μM. 20684599
breast cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human breast cancer cells after 48 hrs, TGI = 7.94 μM. 24747749
Melanoma cells Cytotoxicity assay 48 hrs Cytotoxicity against human melanoma cells after 48 hrs, TGI = 7.94 μM. 24747749
Melanoma cells Cytotoxicity assay 48 hrs Cytotoxicity against human melanoma cells after 48 hrs, TGI = 7.94 μM. 22283430
breast cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human breast cancer cells after 48 hrs, TGI = 7.94 μM. 22283430
Melanoma cells Antitumor assay 48 hrs Antitumor activity against human Melanoma cells after 48 hrs by SRB assay, TGI = 7.94328 μM. 19006285
breast cancer cells Antitumor assay 48 hrs Antitumor activity against human Breast cancer cells after 48 hrs by SRB assay, TGI = 7.94328 μM. 19006285
Leukemia cells Antitumor assay 48 hrs Antitumor activity against human Leukemia cells after 48 hrs by SRB assay, TGI = 15.8489 μM. 19006285
NSCLC Antitumor assay 48 hrs Antitumor activity against human NSCLC cells after 48 hrs by SRB assay, TGI = 15.8489 μM. 19006285
NSCLC Growth inhibition assay 48 hrs Growth inhibition of human NSCLC cells after 48 hrs, TGI = 15.85 μM. 20684599
Leukemia cells Growth inhibition assay 48 hrs Growth inhibition of human leukemia cells after 48 hrs, TGI = 15.85 μM. 20684599
NSCLC Cytotoxicity assay 48 hrs Cytotoxicity against human NSCLC cells after 48 hrs, TGI = 15.85 μM. 22283430
Leukemia cells Cytotoxicity assay 48 hrs Cytotoxicity against human leukemia cells after 48 hrs, TGI = 15.85 μM. 24747749
NSCLC Cytotoxicity assay 48 hrs Cytotoxicity against human NSCLC cells after 48 hrs, TGI = 15.85 μM. 24747749
Leukemia cells Cytotoxicity assay 48 hrs Cytotoxicity against human leukemia cells after 48 hrs, TGI = 15.85 μM. 22283430
renal cancer cells Growth inhibition assay 48 hrs Growth inhibition of human renal cancer cells after 48 hrs, TGI = 19.95 μM. 20684599
ovarian cancer cells Growth inhibition assay 48 hrs Growth inhibition of human Ovarian cancer cells after 48 hrs, TGI = 19.95 μM. 20684599
renal cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human renal cancer cells after 48 hrs, TGI = 19.95 μM. 24747749
ovarian cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human ovarian cancer cells after 48 hrs, TGI = 19.95 μM. 24747749
renal cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human renal cancer cells after 48 hrs, TGI = 19.95 μM. 22283430
ovarian cancer cells Cytotoxicity assay 48 hrs Cytotoxicity against human ovarian cancer cells after 48 hrs, TGI = 19.95 μM. 22283430
ovarian cancer cells Antitumor assay 48 hrs Antitumor activity against human ovarian cancer cells after 48 hrs by SRB assay, TGI = 19.9526 μM. 19006285
renal cancer cells Antitumor assay 48 hrs Antitumor activity against human renal cancer cells after 48 hrs by SRB assay, TGI = 19.9526 μM. 19006285
PC3 Cytotoxicity assay 48 hrs Cytotoxicity against human PC3 cells assessed as inhibition of cell viability after 48 hrs by MTT assay, IC50 = 28.11 μM. 29174816
HEK293/MRP1 Growth Inhibition Assay IC50=0.055±0.0120 μM 24284783
HEK293/pcDNA3.1 Growth Inhibition Assay IC50=0.004±0.0003 μM 24284783
MCF-7 Growth Inhibition Assay IC50=0.0159±0.0062 μM 24704556
MCF-7/ADR Growth Inhibition Assay IC50=4.4826±0.2070 μM 24704556
HepG2 Growth Inhibition Assay IC50=0.0115±0.0017 μM 24704556
HepG2/ADM Growth Inhibition Assay IC50=2.7863±0.2371 μM 24704556
HEK293/ABCC1 Growth Inhibition Assay IC50=19.29 ± 2.08 nM 24726739
HEK293/pcDNA3.1 Growth Inhibition Assay IC50=1.45 ± 0.20 nM 24726739
SW620/AD300 Growth Inhibition Assay IC50=909.60 ± 8.91 nM 24726739
SW620 Growth Inhibition Assay IC50=7.80 ± 0.08 nM 24726739
MCF-7-R Cytotoxicity Assay IC50=5.539 ± 0.144 nM 24858827
A549-R Cytotoxicity Assay IC50=12.178 ± 0.333 nM 24858827
MCF-7-R Growth Inhibition Assay IC50=5.539 ± 0.144 nM 24858827
MCF-7-WT Growth Inhibition Assay IC50=17.752 ± 0.218 nM 24858827
A549-R Growth Inhibition Assay IC50=12.178 ± 0.333 nM 24858827
A549-WT Growth Inhibition Assay IC50=19.437 ± 0.594 nM 24858827
SHSY5Y Growth Inhibition Assay IC50=8.2±0.6 nM 24921920
LAN1 Growth Inhibition Assay IC50=2.3±0.2 nM 24921920
SKNAS Growth Inhibition Assay IC50=1.5±0.2 nM 24921920
IGNR91 Growth Inhibition Assay IC50=24.3±1.7 nM 24921920
SKNBe2C Growth Inhibition Assay IC50=32.8±4.0 nM 24921920
HCT-116 Growth Inhibition Assay GI50=5 nM 24927857
KBv200 (ABCB1) Growth Inhibition Assay IC50=0.3462 ± 0.0066 μM 25058526
KB Growth Inhibition Assay IC50=0.0049 ± 0.0001 μM 25058526
H157 Growth Inhibition Assay IC50=1.03 ± 0.04 miu2M 25257911
W1 Growth Inhibition Assay IC50=0.0032 μM 24140176
W1VR Growth Inhibition Assay IC50=0.056 μM 24140176
K562 Growth Inhibition Assay IC50=0.032 ± 0.001 μM 24135937
K562/ADR Growth Inhibition Assay IC50=3.261 ± 0.412 μM 24135937
A549 Growth Inhibition Assay IC50=0.10 ± 0.03 μM 23971075
A2780 Growth Inhibition Assay IC50=3.5 mM 23829203
ACHN Growth Inhibition Assay IC50<0.1 mM 23829203
U-937 Growth Inhibition Assay IC50<34 nM 23829203
Hep-2 Growth Inhibition Assay IC50=0.04±0.01 μM 23780424
Hep-2/v Growth Inhibition Assay IC50=1.8±0.20 μM 23780424
SGC-7901 Apoptosis Assay induces apoptosis significantly 23743572
SGC-7901/VCR Apoptosis Assay induces apoptosis significantly 23743572
KB-3-1 Growth Inhibition Assay IC50=1.66 ± 0.162 μM 23673445
KB-C2 Growth Inhibition Assay IC50=202.56 ± 42.481 μM 23673445
KB-3-1 Growth Inhibition Assay IC50=1.26 ± 0.027 μM 23673445
KB-V1 Growth Inhibition Assay IC50=208.85 ± 20.4 μM 23673445
HEK293/pcDNA3.1 Growth Inhibition Assay IC50=24.1 ± 0.204 μM 23673445
HEK293/ABCB1 Growth Inhibition Assay IC50=3512.8 ± 378.391 μM 23673445
SGC7901 Growth Inhibition Assay IC50=1.26 ± 0.11 μg/ml 23564482
SGC7901/LV-NC Growth Inhibition Assay IC50=1.77 ± 0.16 μg/ml 23564482
SGC7901/LV-SGO1 Growth Inhibition Assay IC50=4.36 ± 0.37 μg/ml 23564482
SGC7901/VCR Growth Inhibition Assay IC53=20.53 ± 1.96 μg/ml 23564482
SGC7901/VCR-NC Growth Inhibition Assay IC50=19.86 ± 2.01 μg/ml 23564482
SGC7901/VCR-si-SGO1 Growth Inhibition Assay IC50=6.18 ± 1.03 μg/ml 23564482
SGC7901/ADR Growth Inhibition Assay IC50=7.85 ± 0.64 μg/ml 23564482
SGC7901/ADR-NC Growth Inhibition Assay IC50=8.93 ± 0.68 μg/ml 23564482
SGC7901/ADR-si-SGO1 Growth Inhibition Assay IC50=3.46 ± 0.29 μg/ml 23564482
Colon cancer cells Cytotoxicity assay Cytotoxicity against human colon cancer cells, GI50 = 0.1 μM. 18598018
Leukemia cells Cytotoxicity assay Cytotoxicity against human leukemia cells, GI50 = 0.1 μM. 18598018
Leukemia cells Antitumor assay Antitumor activity against leukemia cells, GI50 = 0.1 μM. 17559205
Colon cancer cells Antitumor assay Antitumor activity against colon tumor cells, GI50 = 0.1 μM. 17559205
central nervous system cancer cells Cytotoxicity assay Cytotoxicity against human central nervous system cancer cells, GI50 = 0.12589 μM. 18598018
prostate cancer cells Cytotoxicity assay Cytotoxicity against human prostate cancer cells, GI50 = 0.12589 μM. 18598018
CNS Antitumor assay Antitumor activity against CNS tumor cells, GI50 = 0.12589 μM. 17559205
prostate cancer cells Antitumor assay Antitumor activity against prostate tumor cells, GI50 = 0.12589 μM. 17559205
Melanoma cells Cytotoxicity assay Cytotoxicity against human melanoma cells, GI50 = 0.15849 μM. 18598018
Melanoma cells Antitumor assay Antitumor activity against melanoma cells, GI50 = 0.15849 μM. 17559205
Melanoma cells Growth inhibition assay Growth inhibition of human melanoma cells after 48 hrs, GI50 = 0.16 μM. 20684599
NSCLC Antitumor assay Antitumor activity against NSCLC cells, GI50 = 0.25119 μM. 17559205
Non-small cell lung carcinoma cells Cytotoxicity assay Cytotoxicity against human Non-small cell lung carcinoma cells, GI50 = 0.25119 μM. 18598018
ovarian cancer cells Cytotoxicity assay Cytotoxicity against human ovarian cancer cells, GI50 = 0.31623 μM. 18598018
renal cancer cells Cytotoxicity assay Cytotoxicity against human renal cancer cells, GI50 = 0.31623 μM. 18598018
breast cancer cells Cytotoxicity assay Cytotoxicity against human breast cancer cells, GI50 = 0.31623 μM. 18598018
renal cancer cells Antitumor assay Antitumor activity against renal tumor cells, GI50 = 0.31623 μM. 17559205
ovarian cancer cells Antitumor assay Antitumor activity against ovarian tumor cells, GI50 = 0.31623 μM. 17559205
breast cancer cells Antitumor assay Antitumor activity against breast tumor cells, GI50 = 0.31623 μM. 17559205
COLON Cytotoxicity assay Cytotoxicity against human colon cancer cells, TGI = 3.98107 μM. 18598018
COLON Antitumor assay Antitumor activity against colon tumor cells, TGI = 3.98107 μM. 17559205
central nervous system cancer cells Cytotoxicity assay Cytotoxicity against human central nervous system cancer cells, TGI = 6.30957 μM. 18598018
prostate cancer cells Cytotoxicity assay Cytotoxicity against human prostate cancer cells, TGI = 6.30957 μM. 18598018
CNS Antitumor assay Antitumor activity against CNS tumor cells, TGI = 6.30957 μM. 17559205
prostate cancer cells Antitumor assay Antitumor activity against prostate tumor cells, TGI = 6.30957 μM. 17559205
Melanoma cells Cytotoxicity assay Cytotoxicity against human melanoma cells, TGI = 7.94328 μM. 18598018
breast cancer cells Cytotoxicity assay Cytotoxicity against human breast cancer cells, TGI = 7.94328 μM. 18598018
Melanoma cells Antitumor assay Antitumor activity against melanoma cells, TGI = 7.94328 μM. 17559205
breast tumor cells Antitumor assay Antitumor activity against breast tumor cells, TGI = 7.94328 μM. 17559205
NSCLC Antitumor assay Antitumor activity against NSCLC cells, TGI = 15.8489 μM. 17559205
Non-small cell lung carcinoma cells Cytotoxicity assay Cytotoxicity against human Non-small cell lung carcinoma cells, TGI = 15.8489 μM. 18598018
Leukemia cells Cytotoxicity assay Cytotoxicity against human leukemia cells, TGI = 15.8489 μM. 18598018
Leukemia cells Antitumor assay Antitumor activity against leukemia cells, TGI = 15.8489 μM. 17559205
ovarian cancer cells Cytotoxicity assay Cytotoxicity against human ovarian cancer cells, TGI = 19.9526 μM. 18598018
renal cancer cells Cytotoxicity assay Cytotoxicity against human renal cancer cells, TGI = 19.9526 μM. 18598018
renal tumor cells Antitumor assay Antitumor activity against renal tumor cells, TGI = 19.9526 μM. 17559205
ovarian tumor cells Antitumor assay Antitumor activity against ovarian tumor cells, TGI = 19.9526 μM. 17559205
neural precursor cells Function assay Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay 17417631
他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

生物活性

製品説明 Vincristine sulfate is an inhibitor of polymerization of microtubules by binding to tubulin with IC50 of 32 μM in a cell-free assay. Vincristine sulfate induces apoptosis.
Targets
Microtubules [1]
(Cell-free assay)
32 μM
In Vitro
In vitro Vincristine inhibits net addition of tubulin dimers at assembly ends of steady-state microtubules with Ki of 85 nM. [1] At low concentrations, Vincristine stabilizes the spindle apparatus resulting in failure of the chromosomes to segregate leading to metaphase arrest and inhibition of mitosis. At higher concentrations, Vincristine may disrupt and induce total depolymerization of microtubules. [2] Vincristine induces apoptosis in tumor cells and inhibits SH-SY5Y cell proliferation with IC50 of 0.1 μM. Vincristine induces mitotic arrest and promots the expression of caspase-3 and -9 and cyclin B, while decreasing the expression of cyclin D. [4] Vincristine induced neurotoxicity is caused by interference with microtubule function, which results in blockage of axonal transport and thus in axonal degeneration. [5]
細胞実験 細胞株 B16 melanoma cell
濃度 10 nM
反応時間 3 days
実験の流れ Cells are plated in 2 mL of medium in 35-mm plates at a concentration of about 5 × 104 cells/mL and grow for 24 h at 37 ℃ in an atmosphere of 5% CO2 and 95% air. Then medium is replaced with fresh medium lacking or containing 4 nM drug and proliferation is continued for 3 days. Cell counts are done each day in a Coulter Counter after detaching the cells with trypsin and EDTA.
実験結果図 Methods Biomarkers 結果図 PMID
Western blot MPM2 / Cyclin B1 / Cdc25c / p-Cdc2 / Cdc2 / Aurora B / p-H3 / p-PLK1 26156322
Growth inhibition assay Cell viability 26156322
In Vivo
In Vivo Vincristine (3 mg/kg) administrated by a single i.p. injection to mice bearing bilateral subcutaneous xenografts Rh12 or Rh18, induces mean growth delay of >120 and >52 day, and repopulating fractions of 0.06% and 5%, respectively. [6] Vincristine acts on subcutaneous colon 38 tumors in mice by host cell-mediated vascular effects as well as by direct tubulin-mediated cytotoxicity. Vincristine (5 mg/kg) reduces tumor blood flow of tumors by nearly 75% . [7]
動物実験 動物モデル Human rhabdomyosarcoma xenografts Rh12
投与量 3 mg/kg
投与経路 A single i.p. administration
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05844670 Recruiting
Pediatric Cancer
Moi University|Princess Maxima Center for Pediatric Oncology|Amsterdam UMC location VUmc
 April 20 2023 Phase 4
NCT04448834 Withdrawn
B-cell Acute Lymphoblastic Leukemia
Dorothy Sipkins MD PhD|Amgen|Acrotech Biopharma Inc.|Duke University
 January 2022 Phase 2

化学情報

分子量 923.04 化学式

C46H58N4O14S
CAS No. 2068-78-2 SDF Download Vincristine sulfate SDFをダウンロードする
Smiles CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O
保管

In vitro
Batch:

DMSO : 100 mg/mL ( (108.33 mM)； 吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Water : 100 mg/mL

Ethanol : Insoluble

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

実験計算

モル濃度計算器

質量 濃度 体積 分子量

投与溶液組成計算機(クリア溶液)

ステップ１：実験データを入力してください。（実験操作によるロスを考慮し、動物数を1匹分多くして計算・調製することを推奨します）

mg/kg g μL 匹

ステップ２：投与溶媒の組成を入力してください。（ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください）

% DMSO % % Tween 80 % ddH2O
%DMSO %

計算結果：

投与溶媒濃度： mg/ml;

DMSOストック溶液調製方法： mg 試薬を μL DMSOに溶解する（濃度 mg/mL, 注：濃度が当該ロットのDMSO溶解度を超える場合はご連絡ください。 )

投与溶媒調製方法：Take μL DMSOストック溶液に μL PEG300，を加え、完全溶解後μL Tween 80，を加えて完全溶解させた後 μL ddH2O，を加え完全に溶解させます。

投与溶媒調製方法：μL DMSOストック溶液に μL Corn oil，を加え、完全溶解。

注意：１.ストック溶液に沈殿、混濁などがないことをご確認ください；
２.順番通りに溶剤を加えてください。次のステップに進む前に溶液に沈殿、混濁などがないことを確認してから加えてください。ボルテックス、ソニケーション、水浴加熱など物理的な方法で溶解を早めることは可能です。

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

大学・企業名を記入してください
名前を記入してください
電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
お問い合わせ内容をご入力ください

よくある質問（FAQ）

質問1:
I want to use the product #S1421 for mouse in vivo, could you please give us your advice about administration method?

回答
According to the reference cited on our website, we test the solubility of S1421 Staurosporine in 4% DMSO/saline, and it is a suspension at 5 mg/mL. The compound can also be dissolved in the vehicle 4% DMSO/30% PEG 300/10% Tween 80/saline at 5 mg/ml as a clear solution for injection.

Tags: Vincristine sulfateを買う | Vincristine sulfate ic50 | Vincristine sulfate供給者 | Vincristine sulfateを購入する | Vincristine sulfate費用 | Vincristine sulfate生産者 | オーダーVincristine sulfate | Vincristine sulfate化学構造 | Vincristine sulfate分子量 | Vincristine sulfate代理店